<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="95767">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01902056</url>
  </required_header>
  <id_info>
    <org_study_id>12.0330</org_study_id>
    <nct_id>NCT01902056</nct_id>
  </id_info>
  <brief_title>Implant Placement and Simultaneous Soft Tissue Grafting With Single or Double Layers of Acellular Dermal Matrix</brief_title>
  <official_title>Implant Placement and Simultaneous Soft Tissue Grafting With Single or Double Layers of Acellular Dermal Matrix: A Randomized, Controlled Clinical Tria.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effect on soft tissue thickness of placing
      either a single or double layer of acellular dermal matrix simultaneous with dental implant
      placement. The hypothesis is that 2 layers of acellular dermal matrix will produce thicker
      tissues that one layer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients must be greater that 18 years old, not pregnant, and have an edentulous space with
      a tooth on each side that is treatment planned to receive a dental implant. The primary
      outcome measure is soft tissue thickness.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Soft tissue thickness.</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determining the soft tissue thickness using a tissue probe.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Clinical Efficacy</condition>
  <arm_group>
    <arm_group_label>one layer allograft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One layer allograft as a positive control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Two layer allograft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two layer allograft as the test group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>One layer allograft</intervention_name>
    <description>The acellular dermal matrix was placed on the facial surface.</description>
    <arm_group_label>one layer allograft</arm_group_label>
    <other_name>One layer of acellular dermal matrix (Alloderm).</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Two layer allograft</intervention_name>
    <description>The acellular dermal matrix was placed on the facial surface.</description>
    <arm_group_label>Two layer allograft</arm_group_label>
    <other_name>Two layers of acellular dermal matrix (Alloderm).</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: The inclusion criteria were;

          1. one edentulous site bordered by 2 teeth in the maxilla or mandible from first molar
             to first molar treatment planned to receive an implant

          2. at least 18 years of age

          3. must sign the informed consent -

        Exclusion Criteria: The exclusion criteria included:

          1. uncontrolled diabetes, immune disease, or any systemic disease that significantly
             affects the periodontium

          2. previous head and neck radiation

          3. oral bisphosphonates for &gt; 3 years  or  any IV bisphosphonates

          4. smoking &gt; 1/2 pack per day or other tobacco habits that might interfere with soft
             tissue healing

          5. requirement for prophylactic antibiotics

          6. allergies to any medication or material used in the study, or that would adversely
             affect study procedures

          7. chemotherapy in the previous 12 months

          8. psychological problems that would interfere with treatment

          9. patients unable or unwilling to sign the informed consent

         10. pregnancy -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henry Greenwell, DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Graduate Periodontics Clinic, School of Dentistry, University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 15, 2013</lastchanged_date>
  <firstreceived_date>July 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>Henry Greenwell</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>allograft</keyword>
  <keyword>acellular dermal matrix</keyword>
  <keyword>Alloderm</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
